Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1

FASEB Journal

Volumn 23, Issue 8, 2009, Pages 2478-2489

  Waak, Jens ^a   Weber, Stephanie S ^a   Waldenmaier, Andrea ^b   Görner, Karin ^b   Alunni Fabbroni, Marianna ^b   Schell, Heinrich ^a   Vogt Weisenhorn, Daniela ^c   Pham, Thu Trang ^c   Reumers, Veerle ^d   Baekelandt, Veerle ^d   Wurst, Wolfgang ^c   Kahle, Philipp J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Advalytix Products   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Lipopolysaccharide; Mitogen activated protein kinase; Neuroinflammation; Nitric oxide synthase; Toll like receptor signaling

Indexed keywords

CYCLOOXYGENASE 2; DJ 1 PROTEIN; ENDOTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COMPLEMENTARY DNA; DJ 1 PROTEIN, MOUSE; DJ-1 PROTEIN, MOUSE; ENZYME INHIBITOR; ICAM1 PROTEIN, MOUSE; IMIDAZOLE DERIVATIVE; INTERCELLULAR ADHESION MOLECULE 1; NOS2 PROTEIN, MOUSE; ONCOPROTEIN; PTGS2 PROTEIN, MOUSE; PYRIDINE DERIVATIVE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DEREGULATION; GENETIC ASSOCIATION; INFLAMMATION; LENTIVIRINAE; MEDIATOR; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NEWBORN; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PARKINSONISM; PATHOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; APOPTOSIS; ASTROCYTES; BASE SEQUENCE; CELLS, CULTURED; CYCLOOXYGENASE 2; DNA, COMPLEMENTARY; ENZYME INHIBITORS; IMIDAZOLES; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARKINSONIAN DISORDERS; PYRIDINES; TOLL-LIKE RECEPTOR 4;

EID: 68849097924     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-125153     Document Type: Article

References (45)

1. Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., van Dongen, J. W., Vanacore, N., van Swieten, J. C., Brice, A., Meco, G., van Duijn, C. M., Oostra, B. A., and Heutink, P. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259 (Pubitemid 36131051)
2. Abou-Sleiman, P. M., Healy, D. G., Quinn, N., Lees, A. J., and Wood, N. W. (2003) The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann. Neurol. 54, 283-286
3. Blackinton, J., Ahmad, R., Miller, D. W., van der Brug, M. P., Canet-Avilés, R. M., Hague, S. M., Kaleem, M., and Cookson, M. R. (2005) Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. Mol. Brain Res. 134, 76-83
4. Görner, K., Holtorf, E., Odoy, S., Nuscher, B., Yamamoto, A., Regula, J. T., Beyer, K., Haass, C., and Kahle, P. J. (2004) Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1. J. Biol. Chem. 279, 6943-6951
5. Moore, D. J., Zhang, L., Dawson, T. M., and Dawson, V. L. (2003) A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J. Neurochem. 87, 1558-1567 (Pubitemid 38020589)
6. Takahashi-Niki, K., Niki, T., Taira, T., Iguchi-Ariga, S. M. M., and Ariga, H. (2004) Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. Biochem. Biophys. Res. Commun. 320, 389-397
7. Xu, J., Zhong, N., Wang, H., Elias, J. E., Kim, C. Y., Woldman, I., Pifl, C., Gygi, S. P., Geula, C., and Yankner, B. A. (2005) The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum. Mol. Genet. 14, 1231-1241
8. Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., and Cookson, M. R. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 101, 9103-9108
9. Batelli, S., Albani, D., Rametta, R., Polito, L., Prato, F., Pesaresi, M., Negro, A., and Forloni, G. (2008) DJ-1 modulates α-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70. PLoS ONE 3, e1884 (Pubitemid 351943824)
10. Shendelman, S., Jonason, A., Martinat, C., Leete, T., and Abeliovich, A. (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation. PLoS Biol. 2, e362 (Pubitemid 40280476)
11. Zhou, W., and Freed, C. R. (2005) DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T α-synuclein toxicity. J. Biol. Chem. 280, 43150-43158
12. Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W., and Ting, J. P.-Y. (2006) DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. U. S. A. 103, 15091-15096
13. Fan, J., Ren, H., Jia, N., Fei, E., Zhou, T., Jiang, P., Wu, M., and Wang, G. (2008) DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J. Biol. Chem. 283, 4022-4030
14. Görner, K., Holtorf, E., Waak, J., Pham, T.-T., Vogt-Weisenhorn, D. M., Wurst, W., Haass, C., and Kahle, P. J. (2007) Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1. J. Biol. Chem. 282, 13680-13691
15. Junn, E., Taniguchi, H., Jeong, B. S., Zhao, X., Ichijo, H., and Mouradian, M. M. (2005) Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc. Natl. Acad. Sci. U. S. A. 102, 9691-9696
16. Yang, Y., Gehrke, S., Haque, M. E., Imai, Y., Kosek, J., Yang, L., Beal, M. F., Nishimura, I., Wakamatsu, K., Ito, S., Takahashi, R., and Lu, B. (2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. U. S. A. 102, 13670-13675
17. Chen, L., Cagniard, B., Mathews, T., Jones, S., Koh, H. C., Ding, Y., Carvey, P. M., Ling, Z., Kang, U. J., and Zhuang, X. (2005) Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J. Biol. Chem. 280, 21418-21426
18. Yamaguchi, H., and Shen, J. (2007) Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice. Mol. Neurodegener. 2, 10
19. Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P., Westaway, D., Lozano, A. M., Anisman, H., Park, D. S., and Mak, T. W. (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 102, 5215-5220
20. Manning-Bog, A. B., Caudle, W. M., Perez, X. A., Reaney, S. H., Paletzki, R., Isla, M. Z., Chou, V. P., McCormack, A. L., Miller, G. W., Langston, J. W., Gerfen, C. R., and DiMonte, D. A. (2007) Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiol. Dis. 27, 141-150
21. Goldberg, M. S., Pisani, A., Haburcak, M., Vortherms, T. A., Kitada, T., Costa, C., Tong, Y., Martella, G., Tscherter, A., Martins, A., Bernardi, G., Roth, B. L., Pothos, E. N., Calabresi, P., and Shen, J. (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45, 489-496 (Pubitemid 40249861)
22. Bandopadhyay, R., Kingsbury, A. E., Cookson, M. R., Reid, A. R., Evans, I. M., Hope, A. D., Pittman, A. M., Lashley, T., Canet-Avilés, R., Miller, D. W., McLendon, C., Strand, C., Leonard, A. J., Abou-Sleiman, P. M., Healy, D. G., Ariga, H., Wood, N. W., de Silva, R., Revesz, T., Hardy, J. A., and Lees, A. J. (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127, 420-430 (Pubitemid 38160326)
23. Neumann, M., Müller, V., Görner, K., Kretzschmar, H. A., Haass, C., and Kahle, P. J. (2004) Pathological properties of the Parkinson's disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol. 107, 489-496 (Pubitemid 38765389)
24. Mullett, S. J., Hamilton, R. L., and Hinkle, D. A. (2008) DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age. [E-pub ahead of print] Neuropathology 10.1111/j.1440 -1789.2008.00955.x
25. Hunot, S., and Hirsch, E. C. (2003) Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53(Suppl. 3), S49-S58
26. Hamprecht, B., and Löffler, F. (1985) Primary glial cultures as a model for studying hormone action. Methods Enzymol. 109, 341-345 (Pubitemid 15136041)
27. Geraerts, M., Michiels, M., Baekelandt, V., Debyser, Z., and Gijsbers, R. (2005) Upscaling of lentiviral vector production by tangential flow filtration. J. Gene Med. 7, 1299-1310 (Pubitemid 41555436)
28. Miklossy, J., Doudet, D. D., Schwab, C., Yu, S., McGeer, E. G., and McGeer, P. L. (2006) Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp. Neurol. 197, 275-283
29. Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., and Giuffrida Stella, A. M. (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8, 766-775
30. Guix, F. X., Uribesalgo, I., Coma, M., and Muñoz, F. J. (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 76, 126-152
31. Kawai, T., and Akira, S. (2007) TLR signaling. Semin. Immunol. 19, 24-32
32. Krasowska-Zoladek, A., Banaszewska, M., Kraszpulski, M., and Konat, G. W. (2007) Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation. J. Neurosci. Res. 85, 205-212
33. Guha, M., and Mackman, N. (2001) LPS induction of gene expression in human monocytes. Cell. Signal. 13, 85-94
34. Pawate, S., Shen, Q., Fan, F., and Bhat, N. R. (2004) Redox regulation of glial inflammatory response to lipopolysaccharide and interferon γ. J. Neurosci. Res. 77, 540-551
35. Mitsumoto, A., and Nakagawa, Y. (2001) DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic. Res. 35, 885-893
36. Eddleston, M., and Mucke, L. (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54, 15-36
37. Van Wagoner, N. J., and Benveniste, E. N. (1999) Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100, 124-139
38. Bader, V., Ran Zhu, X., Lübbert, H., and Stichel, C. C. (2005) Expression of DJ-1 in the adult mouse CNS. Brain Res. 1041, 102-111 (Pubitemid 40445394)
39. Nagashima, R., Sugiyama, C., Gotoh, Y., Yoneyama, M., Kuramoto, N., Taira, T., Ariga, H., and Ogita, K. (2008) Altered expression of DJ-1 in the hippocampal cells following in vivo and in vitro neuronal damage induced by trimethyltin. Neurosci. Lett. 440, 232-236
40. Yanagida, T., Takata, K., Inden, M., Kitamura, Y., Taniguchi, T., Yoshimoto, K., Taira, T., and Ariga, H. (2006) Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain. J. Pharmacol. Sci. 102, 243-247
41. Rizzu, P., Hinkle, D. A., Zhukareva, V., Bonifati, V., Severijnen, L.-A., Martinez, D., Ravid, R., Kamphorst, W., Eberwine, J. H., Lee, V. M.-Y., Trojanowski, J. Q., and Heutink, P. (2004) DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann. Neurol. 55, 113-118
42. Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K., and Ichijo, H. (2005) ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6, 587-592
43. Galve-Roperh, I., Malpartida, J. M., Haro, A., Brachet, P., and Díaz-Laviada, I. (1997) Regulation of nerve growth factor secretion and mRNA expression by bacterial lipopolysaccharide in primary cultures of rat astrocytes. J. Neurosci. Res. 49, 569-575
44. Nicholas, C., Batra, S., Vargo, M. A., Voss, O. H., Gavrilin, M. A., Wewers, M. D., Guttridge, D. C., Grotewold, E., and Doseff, A. I. (2007) Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J. Immunol. 179, 7121-7127
45. Mullett, S. J., and Hinkle, D. A. (2009) DJ-1 knock-down in astrocytes impairs astrocyte-mediated neuroprotection against rotenone. Neurobiol. Dis. 33, 28-36